Articles by BCBN

News

StockWatch: Caribou Plunges as It Pursues Strategic Alternatives

October 12, 2026 BCBN Comments Off on StockWatch: Caribou Plunges as It Pursues Strategic Alternatives

Caribou has halted trials of vispacabtagene regedleucel (vispa-cel, formerly CB-010) a treatment for relapsed or refractory B cell non-Hodgkin lymphoma; and of CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of patients with r/r multiple myeloma. The post StockWatch: Caribou Plunges as It Pursues Strategic Alternatives appeared… … […]

No Picture
News

Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting

October 12, 2026 BCBN Comments Off on Stoke Therapeutics Presents Data Supporting the Disease-Modifying Potential of STK-002 in Autosomal Dominant Optic Atrophy (ADOA) at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting

BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced two presentations of data for STK-002 at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting, taking place October 9-12 in New Orleans. STK-002 represents… … […]

No Picture
News

Fujifilm Launches Synapse Pathology v3.0, Advancing the Digital Pathology Experience With Expanded AI Capabilities

October 12, 2026 BCBN Comments Off on Fujifilm Launches Synapse Pathology v3.0, Advancing the Digital Pathology Experience With Expanded AI Capabilities

LEXINGTON, Mass.–(BUSINESS WIRE)–FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, today announced the launch of Synapse® Pathology v3.0. Featuring more than 50 new features and functions, Synapse Pathology v3.0 is designed to enhance the user experience while expanding the platform’s artificial intelligence (AI) capabilities to… … […]

No Picture
News

Insulet Announces Omnipod Discover Now Available in U.S.

October 12, 2026 BCBN Comments Off on Insulet Announces Omnipod Discover Now Available in U.S.

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the U.S. full market release of Omnipod Discover™, a web-based data platform designed for Omnipod 5 users, their caregivers, and healthcare providers (HCPs). Omnipod Discover turns critical diabetes… … […]